1. Home
  2. CUE vs BDL Comparison

CUE vs BDL Comparison

Compare CUE & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.54

Market Cap

49.6M

Sector

Health Care

ML Signal

HOLD

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

HOLD

Current Price

$30.45

Market Cap

56.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUE
BDL
Founded
2014
1959
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
49.6M
56.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
CUE
BDL
Price
$0.54
$30.45
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
361.2K
697.0
Earning Date
11-12-2025
12-26-2025
Dividend Yield
N/A
1.81%
EPS Growth
N/A
41.91
EPS
N/A
2.32
Revenue
$7,100,000.00
$201,851,000.00
Revenue This Year
$36.58
N/A
Revenue Next Year
$32.10
N/A
P/E Ratio
N/A
$13.10
Revenue Growth
N/A
8.84
52 Week Low
$0.53
$22.61
52 Week High
$1.75
$35.98

Technical Indicators

Market Signals
Indicator
CUE
BDL
Relative Strength Index (RSI) 34.41 44.90
Support Level $0.55 $30.00
Resistance Level $0.66 $31.00
Average True Range (ATR) 0.05 0.15
MACD -0.00 -0.16
Stochastic Oscillator 13.24 16.49

Price Performance

Historical Comparison
CUE
BDL

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

Share on Social Networks: